ImmunityBio's total assets for Q4 2025 were $501.90M, a decrease of -3.29% from the previous quarter. IBRX total liabilities were $1.00B for the fiscal quarter, a -3.93% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.